NEW YORK (GenomeWeb News) — Capital Health of Alberta is using PerkinElmer’s mass spectrometers, reagents, and software in a newborn screening program, PerkinElmer said today.

Under a multi-year agreement, the Edmonton-based Capital Health has bought PerkinElmer’s tandem mass spectrometry systems, reagent kits, and its Specimen Gate software to screen newborns for 17 hereditary metabolic disorders, including cystic fibrosis.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.